Keros Therapeutics Appoints Charles Newton to its Board of Directors

Go back to Keros Therapeutics Appoints Charles Newton to its Board of Directors
(NASDAQ: KROS) Delayed: 10.82 -0.21 (1.9%)
Previous Close $11.03    52 Week High
Open $11.12    52 Week Low
Day High $11.12    P/E N/A 
Day Low $10.72    EPS
Volume 47,433